Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males.
Clinical trial NCT04234594 · UNKNOWN
Trial details
- NCT number
- NCT04234594
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-28
- Primary completion
- 2020-09-30
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.